Abstract: A salt of (E)-N-{2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-be?zenesulfonyl]-1H-pyrrol-3-yl)-acrylamide selected from the group consisting of the hydrobromide, methansulfonate, hemi ethane-1,2-disulfonate, benzenesulfonate, toiuenesulfonate and 2-naphthalenesulfonate.

Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4 inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical composition for use, e.g., in treatment of airway disorders.

Abstract: An arrangement for setting at least one RGB luminous module is provided. The arrangement may include at least one RGB sensor configured to detect a color signal; and a processor configured to set the at least one RGB luminous module depending on the color signal.

Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4-inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions for use, e.g., in treatment of airway disorders.

Abstract: The present invention relates to amorphous ciclesonide, methods to prepare the same, pharmaceutical compositions comprising amorphous ciclesonide as active ingredient, and methods of treatment using amorphous ciclesonide.

Abstract: The compounds of a certain formula 1, in which R1, R7, R8, R9 and n have the meanings as given in the description, are novel effective inhibitors of the type 4 phosphodiesterase.

Abstract: Compounds of a certain formula 1, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.

Abstract: Compounds of a certain formula I, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors.

Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.

Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.

Abstract: The invention relates to pantoprazole and (S)-pantoprazole salts and to medicaments comprising these compounds.

Abstract: The invention relates to salts of 6-heteroaryl substituted hexahydrophenanthridine PDE4-inhibiting compounds, which can be used in the pharmaceutical industry for the production of pharmaceutical compositions for use, e.g., in treatment of airway disorders.

Abstract: A method for defining at least one parameter for a finite elements analysis (FEA) calculation in a computer-assisted drafting (CAD) program comprises the steps of determining a body for which said parameter is to be defined, said body being a entity processed by said CAD program; and using at least one graphical function of said CAD program to define a region within a face of said body, said region being used to define a load/support condition for said FEA calculation. A computer program product and an apparatus comprise corresponding features. The present invention provides an improved way of defining parameters like load or support conditions for an FEA calculation in a CAD program.

Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.

Abstract: An inking system for a printing machine which has a relatively simple design and which is adapted for more stable ink transfer to a plate cylinder. The inking system includes an ink supply roller (15), one or more drivable inking unit rollers (14, 19), an adjustment system for establishing a predetermined nip (19) between the ink supply roller and one of the drivable unit inking rollers (14, 19), and at least one movable calender roller (10) in constant contact with one of the drivable inking unit rollers operable for selectively interrupting the ink transfer.

Abstract: An ink metering system for a roller train in a printing machine which in the illustrated embodiment includes a fountain roller and a downstream train of rollers communicating with a plate or form cylinder of the printing press. One or more plating devices (12) are provided which each have a plate-like element (19) adjustably positionable with respect to a respective roller for leveling ink on the surface of the roller before or after passage through a contact zone with an adjacent roller in which ink is pulled off and separated between the rollers. The plating devices are relatively simple in construction and operation and provide stable ink guidance on the roller surfaces that noticeably improves print quality.

Abstract: On stack changing, in a sheet feeder, a remaining-stack carrying device (3) is used, of which the remaining-stack bars (7A, 7B) can be pulled in a staggered manner. For better access, a U-shaped mounting (6) is provided, in which the pull drives (11) of the remaining-stack bars (7) are displaceably mounted.

Abstract: The invention concerns a metering system for the inking of rollers in a printing machine.

Abstract: A remaining-stack carrying device (3) in a sheet feeder (2) is used in non-stop stack changing. The remaining-stack carrying device (3) is integrated into the stack feeder (2) to simplify retrofitting. A remaining-stack lifting gear (5) uses the lifting elements present in each sheet feeder (2) for lifting and lowering during stack exchange.

Abstract: In a stack changing device, on a sheet feeder the remaining stack bars (7A, 7B) are pulled from the stack area, out-of-line in relation to each other. For improved stack joining, the inner remaining stack bars (7A, 7B) are each pulled more slowly than the outer remaining stack bars (7A, 7B).